The FDA Is Not a Referee

0

Last October, the Food and Drug Administration began surveying ground cinnamon products. By November, the agency identified elevated levels of lead and chromium in applesauce pouches across several producers. Suspecting the worst, the FDA mandated recalls and began investigating whether lead was intentionally added to these products. 

Will the Blundering FDA Receive More Power?

0

The House Committee on Oversight and Accountability recently hosted Food and Drug Administration Commissioner Robert Califf in a hearing to discuss the agency’s recent blemishes. The Committee’s website stated that “under the Biden Administration, the FDA has stumbled from crisis to crisis.”

DEA and FDA Duke it Out Over Marijuana Scheduling

0

This November, Floridians will vote on an amendment that would allow citizens over 21 years old to use and possess marijuana for recreational reasons. Early polls indicate bi-partisan support. However, whether the amendment builds enough support to reach the 60 percent approval threshold in the next seven months is anyone’s guess. 

You Can’t Spend Your Way Out of an Opioid Crisis

0

Spending more doesn’t always get you more and that includes money going towards combatting America’s ongoing opioid crisis. But don’t tell that to the Biden Administration.

Did Healthcare Spending Really Return to Pre-Pandemic Levels?

0

2022 was hardly a year of fiscal austerity. Monetary expansion from years before resulted in 8 percent inflation. Congress passed a $1.7 trillion omnibus package and pledged $45 billion in support to Ukraine. The United States also spent nearly $170 billion in public health efforts in 2022 alone, despite President Biden’s statement that the COVID-19 pandemic was over

Another Infant Formula Shortage? Blame the FDA

0

On December 28, 2023, the Food and Drug Administration received information that a sample from a hypoallergenic infant formula called Nutramigen was contaminated with salmonella. Since then, Nutramigen’s producer Reckitt/Mead Johnson Nutrition voluntarily recalled 675,000 cans of formula and began undergoing hygiene and safety inspections conducted by the FDA. The plant is still under inspection.

Gene Therapy: A Promising Medical Frontier Hindered by Regulatory Roadblocks

0

Maddy Smith was diagnosed with Spinal Muscular Atrophy (SMA)—an extremely rare but debilitating genetic disorder—as an infant. SMA is a neuromuscular condition that robs victims of the ability to move, swallow, and sometimes breathe without assistance. Shortly before she turned two, Maddy still lacked the strength to crawl or eat solid foods. 

Who Should Decide if Weight-Loss Injections Should be Prescribed for Kids?

0

The latest statistics from the National Health Institute find about 43 percent of US adults are considered obese. Ten percent of US adults are categorized as severely obese—with BMIs over 40 percent. As alarming as these figures are, childhood and young adult obesity rates aren’t far behind. 

More Oversight Won’t Help the US Baby Formula Market

0

Between September 2021 and February 2022, the Food and Drug Administration received complaints that infants became ill and perished after consuming powdered baby formula. These formulas were eventually traced back to a large manufacturer in Sturgis, Michigan. After a stern warning from the FDA, the plant shut down and issued significant recalls. Other producers quickly followed their lead.

The FDA Should Stay Away from Laboratory Developed Tests

0

In healthcare, tests are our eyes into the body’s secretive operations. Whether being swabbed for COVID-19, tested for a genetic condition, taken a drug test, or undergoing routine blood work ordered by your doctor, you’ve likely used a laboratory developed test (LDT). About 70 percent of all medical decisions in the US are based on LDT results.